Delivering bioactive cyclic peptides that target Hsp90 as prodrugs
Author:
Affiliation:
1. School of Chemistry, University of New South Wales, Sydney, Australia;
2. School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, Australia
Funder
University of New South Wales
Frederick Family Trust
Publisher
Informa UK Limited
Subject
Drug Discovery,Pharmacology,General Medicine
Link
https://tandfonline.com/doi/pdf/10.1080/14756366.2019.1580276
Reference61 articles.
1. Peptide therapeutics: current status and future directions
2. The emergence of peptides in the pharmaceutical business: From exploration to exploitation
3. Macrocyclic peptides as regulators of protein-protein interactions
4. Modeling Peptide-Protein Interactions
5. Structure-Based Design of Inhibitors of Protein-Protein Interactions: Mimicking Peptide Binding Epitopes
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. HSP90 inhibitors and cancer: Prospects for use in targeted therapies (Review);Oncology Reports;2022-11-09
2. Cyclic Peptides as Drugs for Intracellular Targets: The Next Frontier in Peptide Therapeutic Development;Chemistry – A European Journal;2020-11-09
3. Improving Membrane Permeation in the Beyond Rule-of-Five Space by Using Prodrugs to Mask Hydrogen Bond Donors;ACS Chemical Biology;2020-07-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3